Intermediate vancomycin susceptibility in a community-associated MRSA clone. - Wikidata - awgldk - TriplyDB

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

http://www.wikidata.org/entity/Q37302793

about

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Mechanisms of vancomycin resistance in Staphylococcus aureus Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.Antibiotic options for treating community-acquired MRSA.Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.Recurrent furunculosis caused by a community-acquired Staphylococcus aureus strain belonging to the USA300 clone.First report of vancomycin-intermediate resistance in sequence type 72 community genotype methicillin-resistant Staphylococcus aureus.Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent Multiplex PCR for rapid detection of Staphylococcus aureus isolates suspected to represent community-acquired strains.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals Daptomycin in bone and joint infections: a review of the literature.Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population.Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72.Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus.Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.The rise of antimicrobial resistance: a clear and present danger.

P2860

Q24614464-986A4D0B-09BF-4E8F-9C49-1C192E28FF28 Q24620644-C73549A5-5B00-4611-8427-E42DA3E975E3 Q24646677-D43E3D7B-5DEC-4D35-9378-C08F042DC3A0 Q26829312-272A2FD9-4ECD-41B6-8784-73387538702E Q28550691-D9E2784A-1431-48D0-A92E-C6EA3CFE3AE7 Q30394525-72AA52B4-7F4C-41F0-8A59-B361FBA929AA Q34116509-AA0BB2C1-0C2F-452F-997F-29EC25C912FE Q34343212-B23A9642-C77B-45B9-9EC8-9E88282AD12E Q34477769-24CF88FF-8D4D-4E55-9A7B-2B621979405F Q34593646-30813AE8-8C0C-4619-8896-D770F451E802 Q34700948-6B3564C5-2844-4503-88EA-391015B11437 Q34998629-75734FC1-4DAC-4895-AFD5-D858FD110104 Q35035275-BA7D66DE-3D72-4A52-B77E-8BA035A4AE89 Q35618211-A57E732D-71BB-43D3-A598-416CDDB0FE97 Q35728976-BAB7C02D-54BB-484D-90EA-21B12C69B024 Q35900384-8831556A-64C0-4ACF-82AE-62B784B8C984 Q36118613-753FE723-B14D-45C8-97B6-169DCA83A846 Q36265781-F618C114-8380-48C7-B085-3D1D636C2313 Q36452505-1B1451FD-9062-4A50-9269-C5F117B279A4 Q36569841-27C871B5-4258-45F4-9EF2-CF7AA636BE5E Q36876054-A9461177-C088-4E26-9711-BA6E68A1D341 Q37319460-C233833A-463C-458A-8136-276FEB24261A Q37455462-70C765E4-F01A-44E6-9D73-81EAC4746FFE Q37819539-6E0B827B-E874-40FE-AA3F-9F923B41CEC1 Q38051319-3A0BC53F-E0DF-40A7-B74C-028C7D2E650B Q38075466-557D8D9C-7DC6-4202-9CFE-953CE109966B Q38462842-FB7FCF94-6F3D-471B-AC71-48571082FAB6 Q38736105-F96DF273-0A40-4C00-A2CD-1B21346DA458 Q40098505-7E8A6049-A88B-423A-B4C8-56F7E99E38AE Q40988669-8D138B27-E673-40E1-81CF-BFEC0DA54616 Q42003878-44969BD2-16A2-4D73-8622-FF864858E0C9 Q51165933-2FFA750E-F155-4DEA-B589-54D10B555B97

P2860

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

http://www.wikidata.org/entity/Q37302793

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@en

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@nl

type

label

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@en

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@nl

prefLabel

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@en

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@nl

P1433

Q37302793-AF0D854B-7649-4844-B082-8D89588105A6

P1476

Q37302793-EA9CE49D-B3EF-483D-8D46-9B279F0C0C8B

P2093

Q37302793-04E5A449-91E9-40AA-A513-DA4C251BC21F

Q37302793-13671077-F64C-4AD5-977F-49EDF3DD1075

Q37302793-5345C0DD-4C56-4326-86EA-1A216A702CDC

Q37302793-6A0DECCE-1A88-4E8F-B6EC-8E0735273AF1

Q37302793-841809B9-C14D-4480-894F-7927259BA713

Q37302793-E90FE7CF-8725-4096-9977-FE223B46BE35

P2860

Q37302793-26FED406-BFD7-482F-A2D1-12611E75B5D5

Q37302793-2EF6A185-0EB1-4FA4-BB5A-65A2EA8A64CA

Q37302793-3131B82C-162E-47AE-89AC-58B440C19312

Q37302793-539C2FA6-D2F5-4C9D-84AE-37C7D89F0D26

Q37302793-68498F65-BD5D-45CB-A1FE-D292846926AD

Q37302793-721774E7-B606-465D-AAAE-98358D5B81F9

Q37302793-7329C002-0609-4D33-B337-E645B6922E23

Q37302793-7EFD3C0A-28BE-4671-9F5E-7640E67A9FDF

Q37302793-A85F3656-DD21-4FAB-A245-842AD9F35C50

Q37302793-B03BF81C-0A3C-4C86-9CA8-9D00E59739F2

P304

Q37302793-B28B6F0C-30AB-4D3D-893A-A9E8E449B87D

P31

Q37302793-0d091638-1f15-45b4-a6a6-fb100d8616f0

Q37302793-F9508EF4-E889-446A-9011-13DB3648452C

P356

Q37302793-96431A3D-28B4-4F65-A2DB-70DB99CEBFDF

P433

Q37302793-6B599847-F45C-47F5-95E3-9B5935F88CC2

P478

Q37302793-C2B25A5D-6140-4CBA-BD90-6C4D3E573277

P577

Q37302793-3DC6DF4D-DE23-4D55-BA53-A0060FA4D623

P5875

Q37302793-BB216D50-2850-4915-B183-C3DE730DD077

P698

Q37302793-F38D9E54-30A6-40D8-8D0F-ACCD04B61A90

P932

Q37302793-A3B695D3-B4B1-4083-9D41-122E4F46DB25

P356

P1433

Emerging Infectious Diseases

P1476

Intermediate vancomycin susceptibility in a community-associated MRSA clone.

@en

P2093

Barbara L Haller

http://www.w3.org/2001/XMLSchema#string

Christopher J Graber

http://www.w3.org/2001/XMLSchema#string

Françoise Perdreau-Remington

http://www.w3.org/2001/XMLSchema#string

Heather A Carleton

http://www.w3.org/2001/XMLSchema#string

Henry F Chambers

http://www.w3.org/2001/XMLSchema#string

Margaret K Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus.

Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains.

Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States.

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

P304

491-493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1303.060960

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6284817

http://www.w3.org/2001/XMLSchema#string

P698

17552110

http://www.w3.org/2001/XMLSchema#string

P932

2725904

http://www.w3.org/2001/XMLSchema#string